Cytosorbents Corp (CTSO)

Jun 15, 2025

Millennium Management LLC Buys Shares of 33,280 Cytosorbents Co. (NASDAQ:CTSO) - Defense World

Jun 15, 2025

Jun 13, 2025

Cytosorbents announces voting results from annual meeting By Investing.com - Investing.com Canada

Jun 13, 2025

Jun 13, 2025

Cytosorbents announces voting results from annual meeting - Investing.com

Jun 13, 2025

Jun 11, 2025

CytoSorbents Warrants Expire Worthless as Stock Price Fails Threshold - Investing.com

Jun 11, 2025

Jun 04, 2025

Cytosorbents Co. (NASDAQ:CTSO) Shares Purchased by Northern Trust Corp - Defense World

Jun 04, 2025

May 29, 2025

Critical Care Leader CytoSorbents Reveals Growth Strategy at Jefferies Healthcare Conference - Stock Titan

May 29, 2025

May 22, 2025

Cytosorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented At EuroPCR 2025 - marketscreener.com

May 22, 2025

May 22, 2025

CytoSorbents device cuts bleeding in CABG patients - Investing.com

May 22, 2025

May 22, 2025

New Clinical Data: How CytoSorbents' Breakthrough Device Slashes Severe Bleeding Risk in Urgent Heart Surgery - Stock Titan

May 22, 2025

May 21, 2025

Cytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.com - Defense World

May 21, 2025

May 19, 2025

Cytosorbents FY2025 EPS Forecast Lifted by HC Wainwright - Defense World

May 19, 2025

May 17, 2025

D. Boral Capital Reiterates “Buy” Rating for Cytosorbents (NASDAQ:CTSO) - Defense World

May 17, 2025

May 17, 2025

Cytosorbents (NASDAQ:CTSO) Earns Neutral Rating from HC Wainwright - Defense World

May 17, 2025

May 16, 2025

Cytosorbents Corporation (NASDAQ:CTSO) Q1 2025 Earnings Call Transcript - Insider Monkey

May 16, 2025

May 15, 2025

Cytosorbents Corp’s Earnings Call: A Balanced Outlook - TipRanks

May 15, 2025

May 15, 2025

CytoSorbents (CTSO) Receives Neutral Rating from HC Wainwright & Co. | CTSO Stock News - GuruFocus

May 15, 2025

May 15, 2025

CytoSorbents (CTSO) Maintains Buy Rating with $10 Price Target | - GuruFocus

May 15, 2025

May 15, 2025

CytoSorbents (CTSO) Maintains Buy Rating with $10 Price Target | CTSO Stock News - GuruFocus

May 15, 2025

May 15, 2025

CytoSorbents: Q1 Earnings Snapshot - CT Insider

May 15, 2025

May 15, 2025

CytoSorbents Corp (CTSO) Q1 2025 Earnings Call Highlights: Navigating Challenges and ... - Yahoo Finance

May 15, 2025

May 15, 2025

CytoSorbents Corp (CTSO) Q1 2025 Earnings Call Highlights: Navigating Challenges and Strengthening Financials - GuruFocus

May 15, 2025

May 15, 2025

StockNews.com Initiates Coverage on Cytosorbents (NASDAQ:CTSO) - Defense World

May 15, 2025

May 14, 2025

CytoSorbents (CTSO) Targets Growth Amid Regulatory Challenges - GuruFocus

May 14, 2025

May 14, 2025

Earnings call transcript: CytoSorbents Q1 2025 misses earnings, stock dips - Investing.com

May 14, 2025

May 14, 2025

CytoSorbents Corp Q1 2025 Earnings: EPS of -$0.06 Beats Estimate, Revenue of $8.7M Misses Estimate - GuruFocus

May 14, 2025

May 14, 2025

CTSO Reports Q1 Revenue Below Expectations Amid Strategic Changes in Germany | CTSO Stock News - GuruFocus

May 14, 2025

May 14, 2025

CytoSorbents Corporation Q1 2025 Financial Results - TradingView

May 14, 2025

May 14, 2025

CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update - PR Newswire

May 14, 2025

May 14, 2025

Transcript : Cytosorbents Corporation, Q1 2025 Earnings Call, May 14, 2025 - marketscreener.com

May 14, 2025

May 14, 2025

Raymond James Financial Inc. Makes New Investment in Cytosorbents Co. (NASDAQ:CTSO) - Defense World

May 14, 2025

May 13, 2025

CytoSorbents Corp (CTSO) Q1 2025 Earnings Report Preview: What t - GuruFocus

May 13, 2025

May 13, 2025

CytoSorbents's Earnings: A Preview - Nasdaq

May 13, 2025

May 13, 2025

CytoSorbents Corp (CTSO) Q1 2025 Earnings Report Preview: What to Look For - GuruFocus

May 13, 2025

May 07, 2025

Cytosorbents (CTSO) Projected to Post Earnings on Wednesday - Defense World

May 07, 2025

May 05, 2025

Cytosorbents’ (CTSO) “Buy” Rating Reiterated at D. Boral Capital - Defense World

May 05, 2025

May 05, 2025

Cytosorbents (NASDAQ:CTSO) Coverage Initiated at StockNews.com - Defense World

May 05, 2025

May 02, 2025

CytoSorbents (CTSO) Stock: Analyst Maintains "Buy" Rating with $ - GuruFocus

May 02, 2025

May 02, 2025

Behind Cytosorbents Corp’s 52-Week Range: Uncovering Opportunities for Investors - investchronicle.com

May 02, 2025

May 02, 2025

Today’s watch list includes Cytosorbents Corp (NASDAQ:CTSO) stock - uspostnews.com

May 02, 2025

May 02, 2025

CytoSorbents (CTSO) Stock: Analyst Maintains - GuruFocus

May 02, 2025

May 02, 2025

Demystifying CytoSorbents: Insights From 4 Analyst Reviews - Benzinga

May 02, 2025

May 02, 2025

FDA denies CytoSorbents’ request for DrugSorb-ATR device - Investing.com

May 02, 2025

May 02, 2025

CytoSorbents: FDA issues denial letter for De Novo Request for DrugSorb-ATR - TipRanks

May 02, 2025

May 01, 2025

CytoSorbents (CTSO) Awaits FDA Approval for Breakthrough Device DrugSorb-ATR | CTSO Stock News - GuruFocus

May 01, 2025

May 01, 2025

CytoSorbents Provides Regulatory Update for DrugSorb-ATR - PR Newswire

May 01, 2025

May 01, 2025

Cytosorbents (NASDAQ:CTSO) versus Microbot Medical (NASDAQ:MBOT) Financial Analysis - Defense World

May 01, 2025

Apr 30, 2025

CytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights - Longview News-Journal

Apr 30, 2025

Apr 29, 2025

CytoSorbents, Blood Purification Leader, Reveals Q1 2025 Results and Business Updates May 14 - Stock Titan

Apr 29, 2025

Apr 21, 2025

CytoSorbents secures $1.7M via NJ tax credit transfer - Investing.com

Apr 21, 2025

Apr 21, 2025

CytoSorbents Lands $1.7M Strategic Funding: New DrugSorb Product Launch and Manufacturing Expansion Ahead - Stock Titan

Apr 21, 2025

Apr 20, 2025

U.S. FDA Grants Breakthrough Designation To Cytosorb For Removal Of Ticagrelor During Cardiopulmonary Bypass In Emergent And Urgent Cardiothoracic Surgery - Reuters

Apr 20, 2025